TY - JOUR
T1 - Transient telomere dysfunction induces chromosomal instability and promotes carcinogenesis
AU - Begus-Nahrmann, Yvonne
AU - Hartmann, Daniel
AU - Kraus, Johann
AU - Eshraghi, Parisa
AU - Scheffold, Annika
AU - Grieb, Melanie
AU - Rasche, Volker
AU - Schirmacher, Peter
AU - Lee, Han Wong
AU - Kestler, Hans A.
AU - Lechel, André
AU - Rudolph, K. Lenhard
PY - 2012/6/1
Y1 - 2012/6/1
N2 - Telomere shortening limits the proliferative capacity of a cell, but perhaps surprisingly, shortening is also known to be associated with increased rates of tumor initiation. A current hypothesis suggests that telomere dysfunction increases tumor initiation by induction of chromosomal instability, but that initiated tumors need to reactivate telomerase for genome stabilization and tumor progression. This concept has not been tested in vivo, since appropriate mouse models were lacking. Here, we analyzed hepatocarcinogenesis in a mouse model of inducible telomere dysfunction on a telomerase-proficient background, in telomerase knockout mice with chronic telomere dysfunction (G3 mTerc-/-), and in WT mice with functional telomeres and telomerase. Transient or chronic telomere dysfunction enhanced the rates of chromosomal aberrations during hepatocarcinogenesis, but only telomerase-proficient mice exhibited significantly increased rates of macroscopic tumor formation in response to telomere dysfunction. In contrast, telomere dysfunction resulted in pronounced accumulation of DNA damage, cell-cycle arrest, and apoptosis in telomerase-deficient liver tumors. Together, these data provide in vivo evidence that transient telomere dysfunction during early or late stages of tumorigenesis promotes chromosomal instability and carcinogenesis in telomerase-proficient mice.
AB - Telomere shortening limits the proliferative capacity of a cell, but perhaps surprisingly, shortening is also known to be associated with increased rates of tumor initiation. A current hypothesis suggests that telomere dysfunction increases tumor initiation by induction of chromosomal instability, but that initiated tumors need to reactivate telomerase for genome stabilization and tumor progression. This concept has not been tested in vivo, since appropriate mouse models were lacking. Here, we analyzed hepatocarcinogenesis in a mouse model of inducible telomere dysfunction on a telomerase-proficient background, in telomerase knockout mice with chronic telomere dysfunction (G3 mTerc-/-), and in WT mice with functional telomeres and telomerase. Transient or chronic telomere dysfunction enhanced the rates of chromosomal aberrations during hepatocarcinogenesis, but only telomerase-proficient mice exhibited significantly increased rates of macroscopic tumor formation in response to telomere dysfunction. In contrast, telomere dysfunction resulted in pronounced accumulation of DNA damage, cell-cycle arrest, and apoptosis in telomerase-deficient liver tumors. Together, these data provide in vivo evidence that transient telomere dysfunction during early or late stages of tumorigenesis promotes chromosomal instability and carcinogenesis in telomerase-proficient mice.
UR - http://www.scopus.com/inward/record.url?scp=84861794399&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84861794399&partnerID=8YFLogxK
U2 - 10.1172/JCI61745
DO - 10.1172/JCI61745
M3 - Article
C2 - 22622037
AN - SCOPUS:84861794399
SN - 0021-9738
VL - 122
SP - 2283
EP - 2288
JO - Journal of Clinical Investigation
JF - Journal of Clinical Investigation
IS - 6
ER -